Case Report

Priapism and Risperidone

Authors: Sharad Koirala MD, Praveen Penagaluri MD, Carolyn Smith MD, Steven Lippmann MD

Abstract

Abstract:A patient taking oral risperidone while using cocaine and alcohol presented with priapism shortly after long-acting, injectable risperidone was prescribed. Another case of priapism was diagnosed in a sickle cell disease patient who was on oral risperidone. A penectomy due to necrosis was required in the first case, while the other patient regained erectile function. Physicians should be aware of priapism-inducing/predisposing factors, such as sickle cell disease, certain medicines or drugs of abuse, and antipsychotic medications. Risperidone is an established cause of priapism. It occurs especially in males with sickle cell disease; use of antipsychotic drugs and/or cocaine further increases risk.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Compton MT, Miller AH. Priapism associated with conventional and atypical antipsychotic medications: a review. J Clin Psychiatry 2001;62:362–366.ComptonMT]]MillerAHPriapism associated with conventional and atypical antipsychotic medications: a review.J Clin Psychiatry200162362-3662. Cherian J, Rao AR, Thwaini A, et al. Medical and surgical management of priapism. Postgrad Med J 2006;82:89–94.CherianJ]]RaoAR]]ThwainiA&etal;Medical and surgical management of priapism.Postgrad Med J20068289-943. Rosenberg I, Aniskin D, Bernay L. Psychiatric treatment of patients predisposed to priapism induced by quetiapine, trazadone, and risperidone: a case report. Gen Hosp Psychiatry 2009;31:98.RosenbergI]]AniskinD]]BernayLPsychiatric treatment of patients predisposed to priapism induced by quetiapine, trazadone, and risperidone: a case report.Gen Hosp Psychiatry200931984. Makesar D, Thome J. Risperidone-induced priapism. World J Biol Psychiatry 2007;8:45–47.MakesarD]]ThomeJRisperidone-induced priapism.World J Biol Psychiatry2007845-475. Slauson SD, LoVecchio F. Risperidone-induced priapism with rechallenge. J Emerg Med 2004;27:88–89.SlausonSD]]LoVecchioFRisperidone-induced priapism with rechallenge.J Emerg Med20042788-896. Bourgeois JA, Mundh H. Priapism associated with risperidone: a case report. J Clin Psychiatry 2003;64:218–219.BourgeoisJA]]MundhHPriapism associated with risperidone: a case report.J Clin Psychiatry200364218-2197. Nicolson R, McCurley R. Risperidone-associated priapism. J Clin Psychopharmacol 1997;17:133–134.NicolsonR]]McCurleyRRisperidone-associated priapism.J Clin Psychopharmacol199717133-1348. Brant WO, Garcia MM, Bella AJ, et al. T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol 2009;181:1699–1705.BrantWO]]GarciaMM]]BellaAJ&etal;T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.J Urol20091811699-17059. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 1999;60:5–14.RichelsonEReceptor pharmacology of neuroleptics: relation to clinical effects.J Clin Psychiatry1999605-1410. Kirshner A, Davis RR. Priapism associated with the switch from oral to injectable risperidone. J Clin Psychopharmacol 2006;26: 626–628.KirshnerA]]DavisRRPriapism associated with the switch from oral to injectable risperidone.J Clin Psychopharmacol200626626-62811. Altman AL, Seftel AD, Brown SL, et al. Cocaine associated priapism. J Urol 1999;161:1817–1818.AltmanAL]]SeftelAD]]BrownSL&etal;Cocaine associated priapism.J Urol19991611817-181812. Fiorelli RL, Manfrey SJ, Belkoff LH, et al. Priapism associated with intranasal cocaine abuse. J Urol 1990;143:584–585.FiorelliRL]]ManfreySJ]]BelkoffLH&etal;Priapism associated with intranasal cocaine abuse.J Urol1990143584-58513. Rodríguez-Blaáuez HM, Cardona PE, Rivera-Herrera JL. Priapism associated with the use of topical cocaine. J Urol 1990;143:358.Rodríguez-BlaáuezHM]]CardonaPE]]Rivera-HerreraJLPriapism associated with the use of topical cocaine.J Urol199014335814. Mireku-Boateng AO, Tasie B. Priapism associated with intracavernosal injection of cocaine. Urol Int 2001;67:109–110.Mireku-BoatengAO]]TasieBPriapism associated with intracavernosal injection of cocaine.Urol Int200167109-11015. Eland IA, van der Lei J, Striker BH, et al. Incidence of priapism in the general population. Urology 2001;57:970–972.ElandIA]]van der LeiJ]]StrikerBH&etal;Incidence of priapism in the general population.Urology200157970-97216. Mantadakis E, Cavender JD, Rogers ZR, et al. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 1999;21:518–522.MantadakisE]]CavenderJD]]RogersZR&etal;Prevalence of priapism in children and adolescents with sickle cell anemia.J Pediatr Hematol Oncol199921518-522